gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Cancer of Pancreas in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Arora, G; Axtell, AL; Bardeesy, N; Caravan, P; Chawla, A; Chen, YI; Deshpande, V; Erstad, DJ; Farrar, CT; Ferreira, DS; Ferrone, CR; Fuchs, BC; Ghoshal, S; Graham-O'Regan, KA; Humblet, V; Jones, C; Jordan, VC; Kontos, F; Lanuti, M; Li, S; Michelakos, T; Qadan, M; Rotile, NJ; Sojoodi, M; Tanabe, KK; Taylor, MS | 1 |
Andersen, LMK; Galappathi, K; Gaustad, JV; Hauge, A; Rofstad, EK; Simonsen, TG; Wegner, CS | 1 |
Hicks, RM; Hope, TA; Loening, AM; Ohliger, MA; Vasanawala, SS | 1 |
Blanckaert, P; Casneuf, V; Ceelen, WP; Delrue, LJ; Duyck, PC; Peeters, M; Van Damme, N | 1 |
Baum, RP; Bonomo, L; Carreras, C; Castaldi, P; De Gaetano, AM; Giordano, A; Hommann, M; Hörsch, D; Kaemmerer, D; Rufini, V; Treglia, G | 1 |
Laissy, JP; Menu, Y; Sibert, A; Soyer, P; Tidjani, K | 1 |
1 review(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cancer of Pancreas
Article | Year |
---|---|
Role of PET/CT in the functional imaging of endocrine pancreatic tumors.
Topics: Cell Differentiation; Contrast Media; Dopamine Agents; Heterocyclic Compounds; Humans; Levodopa; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Peptide Hormones; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
5 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Cancer of Pancreas
Article | Year |
---|---|
Fibrotic Response to Neoadjuvant Therapy Predicts Survival in Pancreatic Cancer and Is Measurable with Collagen-Targeted Molecular MRI.
Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Chemoradiotherapy, Adjuvant; Collagen; Disease-Free Survival; Female; Fibrosis; Fluorouracil; Follow-Up Studies; Heterocyclic Compounds; Humans; Irinotecan; Leucovorin; Magnetic Resonance Imaging; Male; Mice; Middle Aged; Molecular Imaging; Molecular Probes; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Organometallic Compounds; Oxaliplatin; Pancreas; Pancreatectomy; Pancreatic Neoplasms; Prognosis; Retrospective Studies; Survival Analysis; Xenograft Model Antitumor Assays | 2020 |
Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.
Topics: Animals; Carcinoma, Pancreatic Ductal; Contrast Media; Extracellular Fluid; Female; Heterocyclic Compounds; Heterografts; Humans; Hypoxia; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Mice, Nude; Microvessels; Neoplasm Transplantation; Nitroimidazoles; Organometallic Compounds; Pancreatic Neoplasms; Platelet Endothelial Cell Adhesion Molecule-1; Pressure; Tumor Microenvironment | 2017 |
Variable refocusing flip angle single-shot fast spin echo imaging of liver lesions: increased speed and lesion contrast.
Topics: Adult; Aged; Echo-Planar Imaging; Female; Heterocyclic Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
Topics: Animals; Capillary Permeability; Cell Line, Tumor; Contrast Media; Heterocyclic Compounds; Image Enhancement; Magnetic Resonance Imaging; Male; Mice; Molecular Structure; Molecular Weight; Neovascularization, Pathologic; Organometallic Compounds; Pancreatic Neoplasms; Transplantation, Heterologous | 2011 |
Dynamic Gd-DOTA-enhanced MR imaging of hepatic metastases from pancreatic neuroendocrine tumors.
Topics: Adult; Aged; Carcinoid Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Gastrinoma; Heterocyclic Compounds; Humans; Image Enhancement; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Prospective Studies; Retrospective Studies; Vipoma | 1994 |